Recent studies have highlighted the unique advantages of TCM and its bioactive metabolites in modulating AMPK signaling pathways, improving lipid metabolism, and suppressing inflammation and oxidative stress, offering novel therapeutic strategies for NAFLD. Here, PRKAA1 is linked to metabolic dysfunction-associated steatotic liver disease.